{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:02:18Z","timestamp":1777438938195,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Centre","doi-asserted-by":"publisher","award":["2016\/21\/D\/NZ7\/01548"],"award-info":[{"award-number":["2016\/21\/D\/NZ7\/01548"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005888","name":"Medical University of Lodz","doi-asserted-by":"publisher","award":["564\/3-000-00\/564-20-018"],"award-info":[{"award-number":["564\/3-000-00\/564-20-018"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.cbi.2018.02.012","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T12:37:25Z","timestamp":1518784645000},"page":"126-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Sulfenamide and sulfonamide derivatives of metformin can exert anticoagulant and profibrinolytic properties"],"prefix":"10.1016","volume":"284","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1175-8517","authenticated-orcid":false,"given":"Magdalena","family":"Markowicz-Piasecka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristiina M.","family":"Huttunen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0141ukasz","family":"Mateusiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Mikiciuk-Olasik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Sikora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2018.02.012_bib1","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.2337\/dc09-0459","article-title":"Projecting the future diabetes population size and related costs for the U.S","volume":"32","author":"Huang","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cbi.2018.02.012_bib2","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s40273-015-0268-9","article-title":"The economic costs of type 2 diabetes: a global systematic review","volume":"33","author":"Seuring","year":"2015","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.cbi.2018.02.012_bib3","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1016\/S0149-2918(03)90089-0","article-title":"Metformin hydrochloride in the treatment of type 2 diabetes mellitus: a clinical review with a focus on dual therapy","volume":"25","author":"Setter","year":"2003","journal-title":"Clin. Therapeut."},{"key":"10.1016\/j.cbi.2018.02.012_bib4","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.2174\/1381612822666161201152941","article-title":"Is metformin a perfect drug? Updates in pharmacokinetics and pharmacodynamics","volume":"23","author":"Markowicz-Piasecka","year":"2017","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.cbi.2018.02.012_bib5","first-page":"153","article-title":"Profilaktyka i leczenie trombofilii cukrzycowej w \u015bwietle najnowszych bada\u0144","volume":"4","author":"Kinalska","year":"2003","journal-title":"Diabet. Praktyczna"},{"key":"10.1016\/j.cbi.2018.02.012_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0002-9149(03)00616-7","article-title":"Management of diabetes mellitus and insulin resistance in patients with cardiovascular disease","volume":"92","author":"Fonseca","year":"2003","journal-title":"Am. Col. Cardiol."},{"key":"10.1016\/j.cbi.2018.02.012_bib7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12933-015-0261-9","article-title":"Interplay between ultrastructural findings and atherothrombotic complications in type 2 diabetes mellitus","volume":"14","author":"Soma","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.cbi.2018.02.012_bib8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.20452\/pamw.1201","article-title":"Novel pathway of iron-induced blood coagulation: implications for diabetes mellitus and its complications","volume":"122","author":"Lipinski","year":"2012","journal-title":"Pol. Arch. Med. Wewn."},{"key":"10.1016\/j.cbi.2018.02.012_bib9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12933-016-0373-x","article-title":"Flow cytometric analysis of platelets type 2 diabetes mellitus reveals \u2018angry\u2019 platelets","volume":"15","author":"Soma","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.cbi.2018.02.012_bib10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12933-015-0192-5","article-title":"Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombingenerated fibrin: implications for diagnostics","volume":"14","author":"Pretorius","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.cbi.2018.02.012_bib11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3109\/01913123.2013.778929","article-title":"Albumin stabilizes fibrin fiber ultrastructure in low serum albumin type 2 diabetes","volume":"37","author":"Pretorius","year":"2013","journal-title":"Ultrastruct. Pathol."},{"key":"10.1016\/j.cbi.2018.02.012_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.numecd.2017.04.009","article-title":"Metformin effects on the heart and the cardiovascular system: a review of experimental and clinical data","author":"Nesti","year":"2017","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"key":"10.1016\/j.cbi.2018.02.012_bib13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.atherosclerosis.2013.10.025","article-title":"Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells","volume":"232","author":"Batchuluun","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cbi.2018.02.012_bib14","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.2337\/diacare.16.10.1387","article-title":"Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women","volume":"16","author":"Giugliano","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cbi.2018.02.012_bib15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2796.1991.tb00328.x","article-title":"Treating insulin resistance in hypertension with metformin reduces both blood-pressure and metabolic risk-factors","volume":"229","author":"Landin","year":"1991","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.cbi.2018.02.012_bib16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.amjhyper.2003.11.006","article-title":"Blood pressure and cardiac autonomic nervous system in obese type 2 diabetic patients: effect of metformin administration","volume":"17","author":"Manzella","year":"2004","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.cbi.2018.02.012_bib17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2337\/diacare.16.4.621","article-title":"Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups","volume":"16","author":"Nagi","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cbi.2018.02.012_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejphar.2011.03.029","article-title":"Investigation of the potential effects of metformin on atherothrombotic risk factors in hyperlipidemic rats","volume":"659","author":"Ghatak","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2018.02.012_bib19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S1734-1140(13)70980-0","article-title":"Effect of metformin on selected parameters of hemostasis in fenofibrate-treated patients with impaired glucose tolerance","volume":"65","author":"Krysiak","year":"2013","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.cbi.2018.02.012_bib20","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.2337\/diabetes.54.5.1566","article-title":"Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance","volume":"54","author":"Haffner","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2018.02.012_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/S1262-3636(03)72787-6","article-title":"Beneficial effects of metformin on haemostasis and vascular function in man","volume":"29","author":"Grant","year":"2003","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.cbi.2018.02.012_bib22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1464-5491.1991.tb01610.x","article-title":"Metformin causes a reduction in basal and post-venous occlusion plasminogen activator inhibitor-1 in type 2 diabetic patients","volume":"8","author":"Grant","year":"1991","journal-title":"Diabet. Med."},{"key":"10.1016\/j.cbi.2018.02.012_bib23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2337\/diacare.19.1.64","article-title":"The effects of high- and medium-dose metformin therapy on cardiovascular risk factors in patients with type II diabetes","volume":"19","author":"Grant","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cbi.2018.02.012_bib24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3904\/kjim.1992.7.2.81","article-title":"Plasma tPA and PAI-1 antigen concentrations in non-insulin dependent diabetic patients, effects of treatment modality on fibrinolysis","volume":"7","author":"Cho","year":"1992","journal-title":"Kor. J. Intern. Med."},{"key":"10.1016\/j.cbi.2018.02.012_bib25","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ejphar.2017.06.011","article-title":"New prodrugs of metformin do not influence the overall haemostasis potential and integrity of the erythrocyte membrane","volume":"811","author":"Markowicz-Piasecka","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2018.02.012_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cbi.2017.12.005","article-title":"Biocompatible sulfenamide and sulfonamide derivatives of metformin can exert beneficial effects on plasma haemostasis","volume":"280","author":"Markowicz-Piasecka","year":"2018","journal-title":"Chem.Biol. Int."},{"key":"10.1016\/j.cbi.2018.02.012_bib27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40262-015-0323-x","article-title":"Therapeutic concentrations of metformin: a systematic review","volume":"55","author":"Kajbaf","year":"2016","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.cbi.2018.02.012_bib28","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1021\/jm900274q","article-title":"The first bioreversible prodrug of metformin with improved lipophilicity and enhanced intestinal absorption","volume":"52","author":"Huttunen","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2018.02.012_bib29","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ejps.2013.05.023","article-title":"Convenient microwave-assisted synthesis of lipophilic sulfonamide prodrugs of metformin","volume":"49","author":"Huttunen","year":"2013","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.cbi.2018.02.012_bib30","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1002\/jps.23221","article-title":"In vitro and in vivo evaluation of a sulfenamide prodrug of basic metformin","volume":"101","author":"Huttunen","year":"2012","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.cbi.2018.02.012_bib31","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1365-2516.2008.01856.x","article-title":"Diagnosis and treatment of inherited factor X deficiency","volume":"14","author":"Brown","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.cbi.2018.02.012_bib32","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.pharep.2015.05.021","article-title":"Stability of erythrocyte membrane and overall hemostasis potential - a biocompatibility study of mebrofenin and other iminodiacetic acid derivatives","volume":"67","author":"Markowicz-Piasecka","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.cbi.2018.02.012_bib33","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00394-014-0653-8","article-title":"Extract of Aronia melanocarpa-modified hemostasis: in vitro studies","volume":"53","author":"Sikora","year":"2014","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.cbi.2018.02.012_bib34","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/ajcp\/87.5.619","article-title":"Rapid amidolytic assay of protein C in whole plasma using an activator from the venom of Agkistrodon contortrix","volume":"87","author":"Francis","year":"1987","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.cbi.2018.02.012_bib35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00001721-200003000-00003","article-title":"Measurement of antithrombin activity by thrombin-based and by factor Xa-based chromogenic substrate assays","volume":"11","author":"Beeck","year":"2000","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.cbi.2018.02.012_bib36","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1161\/01.CIR.96.6.1761","article-title":"Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI)","volume":"96","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.cbi.2018.02.012_bib37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1471-2261-14-187","article-title":"Metformin use in patients with type 2 diabetes mellitus is associated with reduced risk of deep vein thrombosis: a non-randomized, pair-matched cohort study","volume":"14","author":"Lu","year":"2014","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.cbi.2018.02.012_bib38","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1016\/j.bmcl.2014.09.019","article-title":"Glutathione-S-transferase selective release of metformin from its sulfonamide prodrug","volume":"24","author":"Rautio","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"1","key":"10.1016\/j.cbi.2018.02.012_bib39","doi-asserted-by":"crossref","first-page":"16470","DOI":"10.1371\/journal.pone.0016470","article-title":"Diabetes mellitus is associated with shortened activated partial thromboplastin time and increased fibrinogen values","volume":"6","author":"Zhao","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2018.02.012_bib40","series-title":"Test Procedures for the Blood Compatibility of Biomaterials","author":"Dawids","year":"1993"},{"key":"10.1016\/j.cbi.2018.02.012_bib41","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jdiacomp.2014.01.006","article-title":"High coagulation factor levels and low protein C levels contribute to enhanced thrombin generation in patients with diabetes who do not have macrovascular complications","volume":"28","author":"Kim","year":"2014","journal-title":"J. Diabet. Complicat."},{"key":"10.1016\/j.cbi.2018.02.012_bib42","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.clinbiochem.2008.10.012","article-title":"Epidemiological association between fasting plasma glucose and shortened APTT","volume":"42","author":"Lippi","year":"2009","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.cbi.2018.02.012_bib43","doi-asserted-by":"crossref","first-page":"26S","DOI":"10.1378\/chest.124.3_suppl.26S","article-title":"The protein C pathway","volume":"124","author":"Esmon","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.cbi.2018.02.012_bib44","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1016\/j.febslet.2005.03.001","article-title":"The anticoagulant protein C pathway","volume":"579","author":"Dahlback","year":"2005","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"key":"10.1016\/j.cbi.2018.02.012_bib45","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/s-0038-1647262","article-title":"Protein C deficiency in insulin-dependent diabetes: a hyperglycemiarelated phenomenon","volume":"64","author":"Ceriello","year":"1990","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.cbi.2018.02.012_bib46","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S1357-2725(03)00244-9","article-title":"Antithrombin: in control of coagulation","volume":"36","author":"Quinsey","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cbi.2018.02.012_bib47","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1056-8727(00)00132-X","article-title":"Diabetes mellitus - a hypercoagulable state","volume":"15","author":"Carr","year":"2001","journal-title":"J. Diabet. Complicat."},{"key":"10.1016\/j.cbi.2018.02.012_bib48","doi-asserted-by":"crossref","first-page":"50895","DOI":"10.18632\/oncotarget.10618","article-title":"Viscoelasticity as a measurement of clot structure in poorly controlled type 2 diabetes patients: towards a precision and personalized medicine approach","volume":"7","author":"Pretorius","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cbi.2018.02.012_bib49","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0049-3848(92)90068-L","article-title":"Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus","volume":"67","author":"Carmassi","year":"1992","journal-title":"Thromb. Res."},{"key":"10.1016\/j.cbi.2018.02.012_bib50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/(SICI)1096-8652(199710)56:2<93::AID-AJH4>3.0.CO;2-W","article-title":"Thrombomodulin and induced tissue factor expression on monocytes as markers of diabetic microangiopathy: a prospective study on haemostasis and lipoproteins in insulin-dependent diabetes mellitus","volume":"56","author":"Reverter","year":"1997","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.cbi.2018.02.012_bib51","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.2337\/diacare.21.11.1967","article-title":"Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity","volume":"21","author":"Charles","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cbi.2018.02.012_bib52","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1161\/CIRCULATIONAHA.110.014860","article-title":"BARI 2D Investigators: profibrinolytic, antithrombotic, and antiinflammatory effects of an insulinsensitizing strategy in patients in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial","volume":"124","author":"Sobel","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cbi.2018.02.012_bib53","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2337\/diabetes.51.1.189","article-title":"The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation","volume":"51","author":"Standeven","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.cbi.2018.02.012_bib54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/joim.12128","article-title":"Long-term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial","volume":"275","author":"de Jager","year":"2014","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.cbi.2018.02.012_bib55","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/1479164110383723","article-title":"Coagulation and fibrinolysis in diabetes","volume":"7","author":"Alzahrani","year":"2010","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"10.1016\/j.cbi.2018.02.012_bib56","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1007\/s00125-005-1742-2","article-title":"The influence of type 2 diabetes on fibrin structure and function","volume":"48","author":"Dunn","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.cbi.2018.02.012_bib57","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00125-006-0197-4","article-title":"Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus","volume":"49","author":"Dunn","year":"2006","journal-title":"Diabetologia"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279717311213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279717311213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:49:13Z","timestamp":1757857753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279717311213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":57,"alternative-id":["S0009279717311213"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2018.02.012","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sulfenamide and sulfonamide derivatives of metformin can exert anticoagulant and profibrinolytic properties","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2018.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}